Novavax at World Vaccine Congress Europe 2026
Oct 19–21, 2026 Amsterdam, Netherlands ~2k attendees Website
Novavax takes part in 2 sessions at World Vaccine Congress Europe 2026 in Amsterdam, and exhibits. Its sessions cover next-generation vaccine technology and its own protein-based approach. The most concrete looks at the potential of the Novavax technology platform, including its Matrix-M adjuvant.
| Organization | World Vaccine Congress Europe 2026 Attendance |
|---|---|
Novavax Gaithersburg, MD | |
Vaccine company developing protein-based vaccines with its Matrix-M adjuvant, including a marketed COVID-19 vaccine. | Booth Exhibiting (no floor booth listed) Talk Tue Oct 20 09:00 The Technology Revolution: Agility for the Wave of Next Generation Vaccines Which newer vaccine platforms, such as RNA, could shorten outbreak response times and extend vaccines to cancer and autoimmune disease. Platforms & delivery Talk Wed Oct 21 14:00 |
Instantly find 20 buyers from Novavax
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Terrapinn or the World Vaccine Congress. Submit a correction